Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pathogenesis(pgns) -- Ignore unavailable to you. Want to Upgrade?

To: Ram Seetharaman who wrote (213)	9/12/1999 6:34:00 PM
From: Sidney Street	Respond to of 228

Maybe, but I happened to be out in Seattle end of August and read in the local paper that Paul Allen's Vulcan group had just upped its holdings - to 8% I think. I haven't looked up the 13D info to confirm that or learn his prices or the dates. More generally, a friend who knows the CF market wasn't surprised at PGNS' difficulty in getting sales - the target doc's are a conservative lot - thinks they will eventually, and he bought the stock in the low teens.